IN2014MU00097A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00097A
IN2014MU00097A IN97MU2014A IN2014MU00097A IN 2014MU00097 A IN2014MU00097 A IN 2014MU00097A IN 97MU2014 A IN97MU2014 A IN 97MU2014A IN 2014MU00097 A IN2014MU00097 A IN 2014MU00097A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Brij Khera
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN97MU2014 priority Critical patent/IN2014MU00097A/en
Priority to US14/593,067 priority patent/US20150196518A1/en
Publication of IN2014MU00097A publication Critical patent/IN2014MU00097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN97MU2014 2014-01-10 2014-01-10 IN2014MU00097A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN97MU2014 IN2014MU00097A (fr) 2014-01-10 2014-01-10
US14/593,067 US20150196518A1 (en) 2014-01-10 2015-01-09 Pharmaceutical compositions of mesalamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN97MU2014 IN2014MU00097A (fr) 2014-01-10 2014-01-10

Publications (1)

Publication Number Publication Date
IN2014MU00097A true IN2014MU00097A (fr) 2015-08-21

Family

ID=54393369

Family Applications (1)

Application Number Title Priority Date Filing Date
IN97MU2014 IN2014MU00097A (fr) 2014-01-10 2014-01-10

Country Status (2)

Country Link
US (1) US20150196518A1 (fr)
IN (1) IN2014MU00097A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3162362A1 (fr) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Comprimé optimisé a une haute dose contenant de la mesalazine
US9867865B1 (en) * 2016-06-30 2018-01-16 Cipla Limited Mesalamine for the treatment of cancer
FR3090317B1 (fr) 2018-12-19 2021-05-07 Cvasthera Utilisation d’un antagoniste de par-1 pour le traitement d’une maladie inflammatoire chronique intestinale
US20220125733A1 (en) * 2020-10-23 2022-04-28 Atoz Pharmaceuticals Pvt Ltd Nongranulated compressed tablets of mesalamine, and process of preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415868A (en) * 1993-06-09 1995-05-16 L. Perrigo Company Caplets with gelatin cover and process for making same
WO1998026767A2 (fr) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Formulations a liberation lente et specifique d'un site, pour l'administration de mesalazine
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US20070059368A1 (en) * 2005-05-31 2007-03-15 Cherukuri S R Modified release formulations of anti-irritability drugs
CN103153944A (zh) * 2010-09-10 2013-06-12 法莫再尔公司 晶态5-氨基水杨酸的制备方法

Also Published As

Publication number Publication date
US20150196518A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
BR112016027639A2 (fr)
BR112016016301A2 (fr)
BR112016016951A2 (fr)
BR112016016224A2 (fr)
BR112016018327A2 (fr)
BR112016015365A2 (fr)
BR112016019697A2 (fr)
BR112016020735A2 (fr)
BR112016030466A2 (fr)
RU2016147527A3 (fr)
BR112016019733A2 (fr)
BR112016021300A2 (fr)
BR112016025669A2 (fr)
BR112016025754A2 (fr)
BR112016030701A2 (fr)
IN2014MU00097A (fr)
RU2017119739A3 (fr)
BR112016018601A2 (fr)
BR112016027960A2 (fr)
JP1538408S (fr)
CN302699702S (fr)
CN302707390S (fr)
CN302704383S (fr)
CN302704429S (fr)
CN302704087S (fr)